Lawmakers behind bipartisan push for legislation detecting and preventing Alzheimer's: 'It's too expensive not to'
#Alzheimer's #legislation #bipartisan #detection #prevention #healthcare costs #lawmakers
📌 Key Takeaways
- Bipartisan lawmakers are advocating for new legislation focused on Alzheimer's detection and prevention.
- The push emphasizes the economic burden of Alzheimer's, arguing proactive measures are cost-effective.
- The legislation aims to address both early detection methods and preventive strategies for the disease.
- Supporters highlight that inaction is more expensive due to long-term care costs and healthcare impacts.
📖 Full Retelling
House Reps. Paul Tonko (D-N.Y.) and Vern Buchanan (R-Fla.), co-sponsors of the Alzheimer's Screening and Prevention (ASAP) Act, said Thursday that proactively addressing Alzheimer's disease is "too expensive" of an issue for Congress to ignore. Appearing at The Hill's "Getting a Diagnosis ASAP: Progress in Early Alzheimer’s Detection" event on Thursday, the two congressmen discussed...
🏷️ Themes
Healthcare Policy, Bipartisan Cooperation
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
House Reps. Paul Tonko (D-N.Y.) and Vern Buchanan (R-Fla.), co-sponsors of the Alzheimer's Screening and Prevention (ASAP) Act, said Thursday that proactively addressing Alzheimer's disease is "too expensive" of an issue for Congress to ignore. Appearing at The Hill's "Getting a Diagnosis ASAP: Progress in Early Alzheimer’s Detection" event on Thursday, the two congressmen discussed...
Read full article at source